Genetic Technologies
GENE
#10879
Rank
โ‚น0.35 B
Marketcap
โ‚น73.88
Share price
0.00%
Change (1 day)
-64.97%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -โ‚น3.21 a decrease over its 2022 EPS that were of -โ‚น2.13.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-โ‚น3.2150.65%
2022-โ‚น2.13-99.04%
2021-โ‚น221.47-46.67%
2020-โ‚น415.25-99.38%
2019-โ‚น66,44010809.09%
2018-โ‚น609.03-41.07%
2017-โ‚น1,034-18.37%
2016-โ‚น1,266-40.24%
2015-โ‚น2,119-53.41%
2014-โ‚น4,547-10.66%
2013-โ‚น5,09071.3%
2012-โ‚น2,971-622.73%
2011โ‚น568.43-108.8%
2010-โ‚น6,459-3.92%
2009-โ‚น6,72373.47%
2008-โ‚น3,87624.96%
2007-โ‚น3,101-10.93%
2006-โ‚น3,482-48.62%
2005-โ‚น6,777-8.31%
2004-โ‚น7,391
2003N/A-100%
2002-โ‚น4,589-9.36%
2001-โ‚น5,063

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,760N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น885.55N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น501.20N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,097N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น35.73N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-โ‚น271.03N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น415.25N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1,58,061N/A๐Ÿ‡บ๐Ÿ‡ธ USA